To provide a systematic overview of worldwide trends in mortality from benign prostatic hyperplasia (BPH) over the past four decades.
This was a descriptive analysis based on age adjusted mortality rates for BPH between 1950 and 1992 for 41 countries from five continents.
Official death certifications from the World Health Organization database.
In the 1950s, the highest age adjusted (on the world standard population) mortality rates for BPH in Europe were in Denmark (22.8/100 000) and Germany (18.1), followed by Scandinavian countries, the UK, and Switzerland.
Italy had rates around 101100 000, and rates were lower in eastern and southern Europe (5-8/100000).
Between 1950 and 1990, a fall of over 90%, or even 95%, was observed in most western European countries.
Thus, in the early 1980s, overall mortality from BPH ranged between 0.5 and 1.5/100 000 in most western European countries.
In proportional terms, similar reductions were registered in other developed countries of North America, Asia (that is, Japan or Singapore), and Oceania.
The most probable interpretation of these trends is that therapeutic improvements - including more widespread and timely surgery, introduction of less invasive techniques, such as transurethral prostatectomy, and possibly the development of medical treatments - have had a favourable and substantial impact on BPH mortality.
Mots-clés Pascal : Hyperplasie, Prostate, Mortalité, Epidémiologie, International, Analyse tendance, Tumeur bénigne, Prostate pathologie, Appareil urinaire pathologie, Appareil génital mâle pathologie
Mots-clés Pascal anglais : Hyperplasia, Prostate, Mortality, Epidemiology, International, Trend analysis, Benign neoplasm, Prostate disease, Urinary system disease, Male genital diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0479825
Code Inist : 002B14D02. Création : 01/03/1996.